Literature DB >> 908205

Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.

S Thorsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 908205

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN： 0907-8916


× No keyword cloud information.
  6 in total

Review 1.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

2.  Fibrinolysis in cornea and conjunctiva: evidence of two types of activators.

Authors:  E Lantz; M Pandolfi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

3.  Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).

Authors:  H Fodstad; I M Nilsson
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

4.  Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.

Authors:  E Suenson; S Thorsen
Journal:  Biochem J       Date:  1981-09-01       Impact factor: 3.857

5.  Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.

Authors:  E G Levin; D J Loskutoff
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

6.  Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth.

Authors:  P Whur; J J Silcox; J A Boston; D C Williams
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.